What is the equity of SI-BONE this year?
SI-BONE has equity of 169.38 M USD this year.
SI-BONE Equity 2024
SI-BONE Equity
169.38 M USD
Ticker
SIBN
ISIN
US8257041090
WKN
A2N7LY
In 2024, SI-BONE's equity was 169.38 M USD, a 72.3% increase from the 98.3 M USD equity in the previous year.
SI-BONE Aktienanalyse
What does SI-BONE do?
SI-BONE Inc. is an innovative medical technology company based in Santa Clara, California. It was founded in 2008 by a group of orthopedic surgeons, engineers, and entrepreneurs who aimed to improve the treatment of lower back pain. The company is now globally recognized and specializes in the development and marketing of implants for the treatment of pain and discomfort in the pelvic and back areas. SI-BONE focuses on the treatment of pain and discomfort in the pelvic and back areas, offering a range of products for this purpose. The company's main focus is on the development of innovative implants that can be used minimally invasively, with the goal of providing patients with quick recovery and improved quality of life. The flagship product of SI-BONE is the iFuse implant. This implant is used in patients with chronic lower back pain caused by instability of the spine or pelvis. The iFuse implant stabilizes the pelvis and thereby reduces the pain originating from the unstable joint region. The iFuse implant has been FDA approved and is now available in over 40 countries worldwide. In addition to the iFuse implant, SI-BONE also offers a variety of other products tailored to the needs of physicians and patients. These include implantable instruments and consumables such as bone screws or arthroscopy needles. SI-BONE is a publicly traded company listed on NASDAQ under the ticker symbol "SIBN." The company's business model is based on providing innovative products to physicians and hospitals that optimize the treatment of back pain. To achieve this, SI-BONE works closely with leading industry professionals to enable optimal treatment of back pain. SI-BONE has established itself as a strong, innovative company specializing in minimally invasive implants in the field of pain therapy. Through close collaboration with physicians and specialists and investment in research and development of cutting-edge technologies, SI-BONE aims to continue growing and achieve a leading position in the field of pain therapy. SI-BONE ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing SI-BONE's Equity
SI-BONE's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding SI-BONE's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating SI-BONE's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
SI-BONE's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in SI-BONE’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about SI-BONE stock
What was the equity of SI-BONE compared to the previous year?
The equity of SI-BONE has increased/decreased by 72.3% increased compared to the previous year.
What impact does a high equity have on investors of SI-BONE?
A high equity is advantageous for investors of SI-BONE as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of SI-BONE?
A low equity can be a risk for investors of SI-BONE, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of SI-BONE affect the company?
An increase in equity of SI-BONE can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of SI-BONE affect the company?
A reduction in equity of SI-BONE can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of SI-BONE?
Some factors that can affect the equity of SI-BONE include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of SI-BONE so important for investors?
The equity of SI-BONE is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can SI-BONE take to change the equity?
To change equity, SI-BONE can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does SI-BONE pay?
Over the past 12 months, SI-BONE paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, SI-BONE is expected to pay a dividend of 0 USD.
What is the dividend yield of SI-BONE?
The current dividend yield of SI-BONE is .
When does SI-BONE pay dividends?
SI-BONE pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of SI-BONE?
SI-BONE paid dividends every year for the past 0 years.
What is the dividend of SI-BONE?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is SI-BONE located?
SI-BONE is assigned to the 'Health' sector.
Wann musste ich die Aktien von SI-BONE kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of SI-BONE from 12/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/4/2024.
When did SI-BONE pay the last dividend?
The last dividend was paid out on 12/4/2024.
What was the dividend of SI-BONE in the year 2023?
In the year 2023, SI-BONE distributed 0 USD as dividends.
In which currency does SI-BONE pay out the dividend?
The dividends of SI-BONE are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The SI-BONE stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von SI-BONE
Our stock analysis for SI-BONE Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of SI-BONE Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
